Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Conformis, Inc. CFMS
$1.16
На 18:00, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
9069773.00000000
-
week52high
11.70
-
week52low
1.07
-
Revenue
62050000
-
P/E TTM
0
-
Beta
1.08823500
-
EPS
-7.50000000
-
Last Dividend
0.00000000
-
Next Earnings Date
08 мая 2023 г. в 12:30
Описание компании
Conformis, Inc., a medical technology company, develops, manufactures, and sells patient-specific products and instrumentation. The company offers personalized knee replacement products, including iUni, iDuo, a custom-made partial knee replacement option for either unicompartmental or bicompartmental osteoarthritis of the knee; iTotal CR, a cruciate retaining total knee replacement product; iTotal PS, a posterior stabilized knee replacement product, as well as provides iTotal Identity and Identity Imprint knee replacement products. It also provides Conformis Hip System and Cordera hip replacement, which are hip replacement products; and iJigs, a personalized single-use patient-specific instrumentation. The company markets and sells its products to orthopedic surgeons, hospitals, and other medical facilities through sales force, independent sales representatives, and distributors in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Spain, Portugal, the Netherlands, Belgium, the Dutch Antilles, Suriname, Australia, the United Arab Emirates, the Sultanate of Oman, Italy, Poland, and other markets. Conformis, Inc. was incorporated in 2004 and is headquartered in Billerica, Massachusetts.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Oppenheimer | Outperform | Outperform | 04 ноя 2021 г. |
| Oppenheimer | Outperform | Outperform | 22 сент 2021 г. |
| Oppenheimer | Outperform | Outperform | 12 мая 2020 г. |
| Oppenheimer | Outperform | Outperform | 02 апр 2019 г. |
| Canaccord Genuity | Buy | Buy | 01 ноя 2018 г. |
| Oppenheimer | Outperform | Outperform | 11 ноя 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| BIENKOWSKI CARRIE | A | 497707 | 130870 | 24 мая 2022 г. |
| FALLON KENNETH P III | A | 507995 | 130870 | 24 мая 2022 г. |
| Milligan Michael D. | A | 253093 | 130870 | 24 мая 2022 г. |
| Langdale Bradley | A | 459502 | 130870 | 24 мая 2022 г. |
| JOHNSTON PHILIP W | A | 481805 | 130870 | 24 мая 2022 г. |
| HOWE ROBERT S | A | 419492 | 419492 | 24 мая 2022 г. |
| HOWE ROBERT S | A | 721199 | 304615 | 24 мая 2022 г. |
| Augusti Mark A | A | 1538136 | 1538136 | 24 мая 2022 г. |
| Fishetti Gary P | A | 261740 | 261740 | 24 мая 2022 г. |
| Augusti Mark A | D | 2433726 | 22396 | 07 мая 2022 г. |
Новостная лента
ConforMIS (CFMS) Reports Q1 Loss, Tops Revenue Estimates
Zacks Investment Research
08 мая 2023 г. в 10:40
ConforMIS (CFMS) came out with a quarterly loss of $1.32 per share versus the Zacks Consensus Estimate of a loss of $1.56. This compares to loss of $2.25 per share a year ago.
Conformis, Inc. (CFMS) Q1 2023 Earnings Call Transcript
Seeking Alpha
08 мая 2023 г. в 10:15
Conformis, Inc. (NASDAQ:CFMS ) Q1 2023 Earnings Conference Call May 8, 2023 8:30 AM ET Company Participants Mark Augusti - President and CEO Bob Howe - CFO and Treasurer Conference Call Participants Eric Anderson - TD Cowen Steve Lichtman - Oppenheimer Joshua Jennings - TD Cowen Operator Good morning, and welcome to the First Quarter 2023 Earnings Conference Call for Conformis, Incorporated. My name is Tanya, and I will be your conference operator today.
Conformis, Inc. to Announce Financial Results for Its First Quarter on May 8, 2023
GlobeNewsWire
13 апр 2023 г. в 16:30
BILLERICA, Mass., April 13, 2023 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today it will release its financial results for the first quarter ended March 31, 2023, before the market opens on Monday, May 8, 2023.
ConforMIS (CFMS) Moves to Buy: Rationale Behind the Upgrade
Zacks Investment Research
06 мар 2023 г. в 13:33
ConforMIS (CFMS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Conformis, Inc. (CFMS) Q4 2022 Earnings Call Transcript
Seeking Alpha
01 мар 2023 г. в 21:49
Conformis, Inc. (NASDAQ:CFMS ) Q4 2022 Results Conference Call March 1, 2023 4:30 PM ET Company Participants Mark Augusti - President and Chief Executive Officer Bob Howe - CFO and Treasurer Conference Call Participants Steven Lichtman - Oppenheimer Eric Anderson - Cowen Operator Good afternoon, and welcome to the Fourth Quarter and Full Year 2022 Earnings Conference Call for Conformis, Inc. My name is Josh, and I will be your conference operator today. All lines have been placed on listen-only mode to prevent any background noise.